Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Molecular Imaging: Principals and Practice. Weissleder R, Ross BD, Rehemetulla A, Gambhir SG (Eds). People’s Medical Publishing House, USA (2010).
  Google Scholar
• 2  Zarbin MA, Montemagno C, Leary JF, Ritch R: Nanomedicine in ophthalmology: the new frontier. Am J. Ophthalmol.150,144–162 (2010).
  Medline CASGoogle Scholar
• 3  Buxton DB: Nanomedicine for the management of lung and blood diseases. Nanomedicine (Lond.)4,331–339 (2009).
  CASGoogle Scholar
• 4  Godin B, Sakamoto JH, Serda RE et al.: Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. Trends Pharmacol. Sci.31,199–205 (2010).
  Medline CASGoogle Scholar
• 5  McCarron PA, Faheem AM: Nanomedicine-based cancer targeting: a new weapon in an old war. Nanomedicine (Lond).5,3–5 (2010).
  Google Scholar
• 6  Laurent S, Forge D, Port M et al.: Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev.108,2064–2110 (2008).
  Medline CASGoogle Scholar
• 7  Bulte JWM, Kraitchman DL: Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed.17,484–499 (2004).
  Medline CASGoogle Scholar
• 8  Terreno E, Castelli DD, Viale A et al.: Challenges for molecular magnetic resonance imaging. Chem. Rev.110,3019–3042 (2010).
  Medline CASGoogle Scholar
• 9  Gupta AK, Gupta M: Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials26,3995–4021 (2005).
  Medline CASGoogle Scholar
• 10  Zhang L, Xue H, Gao C et al.: Imaging and cell targeting characteristics of magnetic nanoparticles modified by a functionalizable zwitterionic polymer with adhesive 3,4-dihydroxyphenyl-L-alanine linkages. Biomaterials31,6582–6588 (2010).
  Medline CASGoogle Scholar
• 11  Bulte JWM, Douglas T, Witwer B et al.: Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol.19,1141–1147 (2001).
  Medline CASGoogle Scholar
• 12  Soenen SJH, Hodenius M, Schmitz-Rode T, De Cuyper M: Protein-stabilized magnetic fluids. J. Magn. Magn. Mater.320,32–39 (2008).
  Google Scholar
• 13  De Cuyper M, Hodenius M, Ivanova G et al.: Specific heating power of fatty acid and phospholipid stabilized magnetic fluids in an alternating magnetic field. J. Phys. Cond. Matter.20,204131.1–204131.5 (2008).
  Medline CASGoogle Scholar
• 14  Mulder WJM, Strijkers GJ, Tilborg GAF, Griffioen AW, Nicolay K: Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed.19,142–164 (2006).▪▪ Overviews different lipidic nanoparticles, conjugation strategies and application in the field of cellular and molecular MRI.
  Medline CASGoogle Scholar
• 15  De Cuyper M, Joniau M: Magnetoliposomes: formation and structural characterization. Eur. Biophys. J.15,311–319 (1988).
  Medline CASGoogle Scholar
• 16  Jiao Y, Peng ZH, Zhang JY, Qin J, Zhong CP: Liposome-mediated transfer can improve the efficacy of islet labeling with superparamagnetic iron oxide. Transplant. Proc.40,3615–3618 (2008).
  Medline CASGoogle Scholar
• 17  Yu Y, Anthony SM, Bae SC et al.: Biomolecular science of liposome–nanoparticle constructs. Mol. Cryst. Liq. Cryst.507,18–25 (2009).
  CASGoogle Scholar
• 18  Soenen SJH, Hodenius M, De Cuyper M: Magnetoliposome: innovative nanocolloids for use in biotechnology and biomedicine. Nanomedicine4,177–191 (2009).▪▪ Comprehensive review regarding magnetoliposomes and their use in several biomedical applications.
  CASGoogle Scholar
• 19  Al-Jamal W, Kostarelos K: Liposome–nanoparticle hybrids for multimodal diagnostic and therapeutic applications. Nanomedicine (Lond).2,85–98 (2007).▪ Liposome–nanoparticle hybrid systems are described, both in terms of their structural characteristics and their potential as diagnostic and therapeutic multimodality agents.
  CASGoogle Scholar
• 20  Torchilin VP: Recent approaches to intracellular delivery of drugs and DNA and onganelle targeting. Annu. Rev. Biomed. Eng.8,343–375 (2006).
  Medline CASGoogle Scholar
• 21  Lawrence MJ, Rees GD: Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev.45,89–121 (2000).
  Medline CASGoogle Scholar
• 22  Torchilin VP: PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv. Drug Deliv. Rev.54,235–252 (2002).
  Medline CASGoogle Scholar
• 23  Torchilin VP: Surface-modified liposomes in γ- and MR-imaging. Adv. Drug Deliv. Rev.24,301–313 (1997).
  CASGoogle Scholar
• 24  Margolis LB, Namiot VA, Kljukin LM: Magnetoliposomes: another principle of cell sorting. Biochim. Biophys. Acta735,193–195 (1983).
  Medline CASGoogle Scholar
• 25  Sahoo Y, Pizem H, Fried T et al.: Alkyl phosphonate/phosphate coating on magnetite nanoparticles: a comparison with fatty acids. Langmuir17,7907–7911 (2001).
  CASGoogle Scholar
• 26  De Cuyper M, Caluwier D, Baert J, Cocquyt J, Van der Meeren P: A successful strategy for the production of cationic magnetoliposomes. Z. Phys. Chem.220,133–141 (2006).
  CASGoogle Scholar
• 27  Soenen SJH, Baert J, De Cuyper M: Optimal conditions for labeling of 3T3 fibroblasts with magnetoliposomes without affecting cellular viability. ChemBioChem8,2067–2077 (2007).
  Medline CASGoogle Scholar
• 28  Martina MS, Fortin JP, Menager C et al.: Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. J. Am. Chem. Soc.127,10676–10685 (2005).
  Medline CASGoogle Scholar
• 29  Sabate R, Barnadas-Rodriguez R, Callejas-Fernandez J, Hidalgo-Alvarez R, Estelrich J: Preparation and characterization of extruded magnetoliposomes. Int. J. Pharm.347,156–162 (2008).
  Medline CASGoogle Scholar
• 30  Janib SM, Moses AS, MacKay JA: Imaging and drug delivery using theranostic nanoparticles. Adv. Drug Del. Rev.62,1052–1063 (2010).
  Medline CASGoogle Scholar
• 31  Fang C, Zhang M: Nanoparticle-based theragnostics: integrating diagnostic and therapeutic potentials in nanomedicine. J. Control. Release89,47–55 (2010).
  Google Scholar
• 32  Chen Y, Bose A, Bothun GD: Controlled release from bilayer decorated magnetoliposomes via electromagnetic heating. ACS Nano.4,3215–3221 (2010).
  Medline CASGoogle Scholar
• 33  Rinck PA: Magnetic Resonance in Medicine. Wiley-Blackwell, Berlin, Germany (2003).
  Google Scholar
• 34  Laurent S, Vander Elst L, Roch A, Muller RN: Structure, synthesis and characterization of contrast agents for magnetic resonance molecular imaging. In: NMR-MRI, µSR and Mössbauer Spectroscopies in Molecular Magnets. Carretta P, Lascialfari A (Eds). Springer, Milano, Italy, 71–87 (2007).
  Google Scholar
• 35  Geraldes CFGC, Laurent S: Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Med. Mol. Imaging4,1–23 (2009).
  Medline CASGoogle Scholar
• 36  The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. Merbach AE, Toth E (Eds). John Wiley, England, UK (2001).
  Google Scholar
• 37  Waters EA, Wickline SA: Contrast agents for MRI. Basic Res. Cardiol.103,114–121 (2008).
  Medline CASGoogle Scholar
• 38  Yan G-P, Robinson L, Hogg P: Magnetic resonance imaging contrast agents: overview and perspectives. Radiography13,E5–E19 (2007).
  Google Scholar
• 39  Terreno E, Delli Castelli D, Aime S: Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents. Contrast Media Mol. Imaging5,78–98 (2010).
  Medline CASGoogle Scholar
• 40  Viswanathan S, Kovacs Z, Ratnakar SJ, Green KN, Sherry AD: Alternatives to gadolinium-based metal chelates for magnetic resonance imaging. Chem. Rev.110,2960–3018 (2010).
  Medline CASGoogle Scholar
• 41  Taboada E, Rodriguez E, Roig A, Oro J, Roch A, Muller RN: Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T₁ magnetic resonance imaging contrast agents for molecular imaging. Langmuir23,4583–4588 (2007).
  Medline CASGoogle Scholar
• 42  Stuber M, Gilson WD, Schär M et al.: Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magnet. Reson. Med.58,1072–1077 (2007).
  MedlineGoogle Scholar
• 43  Senpan A, Caruthers SD, Rhee I et al.: Conquering the dark side: colloidal iron oxide nanoparticles. ACS Nano.3,3917–3926 (2009).
  Medline CASGoogle Scholar
• 44  Mornet S, Portier J, Doguet E: A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran. J. Magn. Magn. Mater.293,127–134 (2005).
  CASGoogle Scholar
• 45  Mornet S, Vasseur S, Grasset F, Guguet E: Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem.14,2161–2175 (2004).
  CASGoogle Scholar
• 46  Arbab AS, Bashaw LA, Miller BR et al.: Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology229,838–846 (2003).
  MedlineGoogle Scholar
• 47  Bulte JW, De Cuyper M: Magnetoliposomes as contrast agents. Methods Enzymol.373,175–198 (2003).
  Medline CASGoogle Scholar
• 48  Yang C, Rait A, Pirollo KF et al.: Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo. Nanomedicine4,318–329 (2008).
  Medline CASGoogle Scholar
• 49  Fortin-Ripoche J-P, Martina MS, Gazeau F et al.: Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. Radiology239,415–424 (2006).
  MedlineGoogle Scholar
• 50  Bulte JWM, De Cuyper M, Despres D, Frank JA: Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent. J. Magn. Magn. Mater.194,204–209 (1999).
  CASGoogle Scholar
• 51  De Cuyper M, Soenen SJH, Coenegrachts K, Beek L T: Surface functionalization of magnetoliposomes in view of improving iron oxide-based magnetic resonance imaging contrast agents: anchoring of gadolinium ions to a lipophilic chelate. Anal. Biochem.367,266–273 (2007).
  Medline CASGoogle Scholar
• 52  Soenen SJH, Desender L, De Cuyper M: Complexation of gadolinium(III) ions on top of nanometer-sized magnetoliposomes. Int. J. Environ. An. Ch.87,783–796 (2007).
  CASGoogle Scholar
• 53  Zaidi H, Prasad R: Advances in multimodality molecular imaging. J. Med. Phys.34,122–128 (2009).
  MedlineGoogle Scholar
• 54  Weissleder R, Pittet MJ: Imaging in the era of molecular oncology. Nature452,580–589 (2008).
  Medline CASGoogle Scholar
• 55  Soenen SJH, Vercauteren D, Braeckmans K, Noppe W, De Smedt S, De Cuyper M: Stable long-term intracellular labelling with fluorescently tagged cationic magnetoliposomes. ChemBioChem10,257–267 (2009).▪ Describes the production of different types of fluorescently tagged magnetoliposomes.
  Medline CASGoogle Scholar
• 56  Van Tilborg GA, Mulder WJ, Deckers N et al.: Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. Bioconjug. Chem.17,741–749 (2006).
  Medline CASGoogle Scholar
• 57  Plassat V, Martina MS, Barratt G, Menager C, Lesieur S: Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: pharmacokinetics and biodistribution. Int. J. Pharm.344,118–127 (2007).
  Medline CASGoogle Scholar
• 58  Martina MS, Wilhelm C, Lesieur S: The effect of magnetic targeting on the uptake of magnetic-fluid-loaded liposomes by human prostatic adenocarcinoma cells. Biomaterials29,4137–4145 (2008).
  Medline CASGoogle Scholar
• 59  Fang C, Zhang M: Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine. J. Control. Release146,2–5 (2010).
  Medline CASGoogle Scholar
• 60  Ozdemir V, Williams-Jones B, Glatt SJ et al.: Shifting emphasis from pharmacogenomics to theragnostics. Nat. Biotechnol.24,942–946 (2006).
  Medline CASGoogle Scholar
• 61  Maeng JH, Lee D-H, Jung KH et al.: Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials31,4995–5006 (2010).
  Medline CASGoogle Scholar
• 62  Weissleder R: Molecular imaging in cancer. Science312,1168–1171 (2006).
  Medline CASGoogle Scholar
• 63  Kim K, Kim JH, Park H et al.: Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring. J. Control. Release146,219–227 (2010).
  Medline CASGoogle Scholar
• 64  Veiseh O, Gunn JW, Zhang M: Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Del. Rev.62,284–304 (2010).
  Medline CASGoogle Scholar
• 65  Torchilin V: Multifunctional and stimuli-sensitive pharmaceutical nanocarriers, Eur. J. Pherm. Biopharm.71,431–444 (2009).
  Medline CASGoogle Scholar
• 66  Bharali DJ, Mousa SA: Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacol. Therapeut.128,324–335 (2010).
  Medline CASGoogle Scholar
• 67  Shubayev VI, Pisanic TR, Jin S: Magnetic nanoparticles for theragnostics. Adv. Drug Del. Rev.61,467–477 (2010).
  Google Scholar
• 68  Pradhan P, Giri J, Banerjee R, Bellarea J, Bahadur D: Preparation and characterization of manganese ferrite-based magnetic liposomes for hyperthermia treatment of cancer. J. Magn. Magn. Mater.311,208–215 (2007).
  CASGoogle Scholar
• 69  Soenen SJH, Cocquyt J, Defour L, Saveyn P, Van der Meeren, De Cuyper M: Design and development of magnetoliposome-based theragnostics. Mater. Manuf. Process.23,611–614 (2008).
  CASGoogle Scholar
• 70  Wang M, Thanou M: Targeting nanoparticles to cancer. Pharmacol. Res.62,90–99 (2010).
  Medline CASGoogle Scholar
• 71  McCarthy JR, Weissleder R: Multifunctional magnetic nanoparticles for targeted imaging and therapy, Adv. Drug Del. Rev.60,1241–1251 (2008).
  Medline CASGoogle Scholar
• 72  Tai LA, Tsai PJ, Wang YC et al.: Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release. Nanotechnology20,135101–135110 (2009).
  MedlineGoogle Scholar
• 73  Chen Y, Bose A, Bothun GD: Controlled release from bilayer-decorated magnetoliposomes via electromagnetic heating. ACS Nano.4,3215–3221 (2010).
  Medline CASGoogle Scholar
• 74  Pradhan P, Giri J, Rieken F et al.: Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J. Control. Release142,108–121 (2010).
  Medline CASGoogle Scholar
• 75  Jain TK, Richey J, Strand M, Dimitrijevic S, Flask CA, Labhasetwar V: Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials29,4012–4021 (2008).
  Medline CASGoogle Scholar
• 76  Jain TK, Foy SP, Erokwu B, Dimitrijevic S, Flask CA, Labhasetwar V: Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials30,6748–6756 (2009).
  Medline CASGoogle Scholar
• 77  Lee H, Yu MK, Park S et al.: Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. J. Am. Chem. Soc.129,12739–12745 (2007).
  Medline CASGoogle Scholar
• 78  Yu MK, Jeong YY, Park J et al.: Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew. Chem. Int. Ed.47,5362–5365 (2008).
  Medline CASGoogle Scholar
• 79  Sahiner N, Ilgin P: Multiresponsive polymeric particles with tunable morphology and properties based on acrylonitrile (AN) and 4-vinylpyridine (4-VP). Polymer51,3156–3163 (2010).
  CASGoogle Scholar
• 80  Huh MS, Lee S-Y, Park S et al.: Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. J. Control. Release144,134–143 (2010).
  Medline CASGoogle Scholar
• 81  Kim K, Kim JH, Park H et al.: Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring. J. Control. Release146,219–227 (2010).
  Medline CASGoogle Scholar
• 82  Yang X, Grailer JJ, Rowland IJ et al.: Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging. Biomaterials31,9065–9073 (2010).
  Medline CASGoogle Scholar
• 83  Nanotoxicity: From In Vivo and In Vitro Models to Health Risks. Sahu SC, Casciano DA (Eds). John Wiley, UK (2009).
  Google Scholar
• 84  Soenen SJH, De Cuyper M: Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol. Imaging4,207–219 (2009).▪ Discusses the cytotoxicity assessment of iron oxide nanoparticles by different methods on magnetoliposome model.
  Medline CASGoogle Scholar
• 85  Garcia VAP, Lacava LM, Kuckelhaus S et al.: Magnetoliposome evaluation using cytometry and micronucleus test. Eur. Cells Mater.3,154–155 (2002).
  Google Scholar
• 86  Lacava ZGM, Garcia VAP, Lacava LM et al.: Biodistribution and biocompatibility investigation in magnetoliposome treated mice. Spectroscopy18,597–603 (2004).
  CASGoogle Scholar
• 87  Lv H, Zhang S, Wang B, Cui S, Yan J: Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release114,100–109 (2006).
  Medline CASGoogle Scholar
• 88  Soenen SJH, Himmelreich U, Nuytten N, Pisanic TR, Ferrari A, De Cuyper M: Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. Small6,2136–2145 (2010).
  Medline CASGoogle Scholar
• 89  Slotkin JR, Cahill KS, Tharin SA, Shapiro EM: Cellular magnetic resonance imaging: nanometer and micrometer size particles for noninvasive cell localization. Neurotherapeutics4,428–433 (2007).
  MedlineGoogle Scholar
• 90  Li P, Li D, Zhang L, Li G, Wang E: Cationic lipid bilayer coated gold nanoparticle-mediated transfection of mammalian cells. Biomaterials29,3617–3624 (2008).
  Medline CASGoogle Scholar
• 91  Soenen SJH, Brisson A, De Cuyper M: Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials30,3691–701 (2009)
  Medline CASGoogle Scholar
• 92  Soenen SJ, Illyes E, Vercauteren D et al.: The role of nanoparticle concentration-dependent induction of cellular stress in the internalization of non-toxic cationic magnetoliposomes. Biomaterials30,6803–6813 (2009).
  Medline CASGoogle Scholar
• 93  Soenen SJH, Himmelreich U, Nuytten N, De Cuyper M: Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labeling. Biomaterials32,195–205 (2011).
  Medline CASGoogle Scholar